E
EuBiologics Co Ltd
KOSDAQ:206650
EuBiologics Co Ltd
KOSDAQ:206650
Price:
14 120
KRW
-1.4%
Market Cap:
₩518.5B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
E
|
EuBiologics Co Ltd
KOSDAQ:206650
|
KR |
|
M
|
Major Development PCL
SET:MJD
|
TH |
|
Tianjin Printronics Circuit Corp
SZSE:002134
|
CN |
|
E
|
Eluon Corp
KOSDAQ:065440
|
KR |
|
J
|
JG Summit Holdings Inc
XPHS:JGS
|
PH |
|
P
|
Psyence Group Inc
CNSX:PSYG
|
CA |
|
A
|
Acrysil Ltd
NSE:ACRYSIL
|
IN |
|
A
|
APAC Resources Ltd
HKEX:1104
|
HK |
|
Daifuku Co Ltd
TSE:6383
|
JP |
|
Mutoh Holdings Co Ltd
TSE:7999
|
JP |
Relative Value
The Relative Value of one EuBiologics Co Ltd stock under the Base Case scenario is hidden KRW. Compared to the current market price of 14 120 KRW, EuBiologics Co Ltd is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
EuBiologics Co Ltd Relative Value
HIDDEN
Multiples Across Competitors
Competitors Multiples
EuBiologics Co Ltd Competitors
EuBiologics Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| KR |
E
|
EuBiologics Co Ltd
KOSDAQ:206650
|
517.1B KRW | 3.4 | 10.5 | 6.3 | 7.3 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
362.5B USD | 5.9 | 86.6 | 14.4 | 20 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
187.5B USD | 5.1 | 24.3 | 14.1 | 14.1 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
170.3B USD | 5.8 | 20 | 12.5 | 15.5 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
115.3B USD | 9.6 | 29.2 | 21.9 | 22.9 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
77.5B USD | 5.4 | 17.2 | 12.6 | 14.4 | |
| AU |
|
CSL Ltd
ASX:CSL
|
66.8B AUD | 3.1 | 33.9 | 11.2 | 14.1 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 | |
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
41.3B USD | 11.1 | 131.9 | 73.8 | 82 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
